Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

François‐Clément Bidard, Anne‐Claire Hardy‐Bessard, Florence Dalenc, +55

The Lancet Oncology

Breast OncologyEsr1 MutationEndocrine-related CancerMedicinePharmacology +8

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette, +140

The Lancet Oncology

Gortec 2014-01 TpextremeNeoadjuvant TherapyMedicineCisplatin Versus PlatinumHead And Neck Cancer +9

Sarcopenia is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma treated with immunochemotherapy

Hélène Lanic, Jérôme Kraut-Tauzia, Romain Modzelewski, +7

Leukemia & lymphoma/Leukemia and lymphoma

Prognostic impact of fat tissue loss and cachexia assessed by computed tomography scan in elderly patients with diffuse large <scp>B</scp>‐cell lymphoma treated with immunochemotherapy

Vincent Camus, Hélène Lanic, Jerome R. Kraut, +16

European Journal Of Haematology

Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

Thomas Grinda, Alison Antoine, William Jacot, +24

ESMO Open

Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study

Xu-Shan Sun, Yungan Tao, Christophe Le Tourneau, +30

The Lancet Oncology

Radiation TherapyMedicineHigh-dose Cisplatin ChemoradiotherapyHead And Neck CancerDebio 1143 +7

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours

David Sefrioui, France Blanchard, Emmanuel Touré, +19

British Journal of Cancer

A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment

Zuzana Saidak, Simon Soudet, Marine Lottin, +4

Cancer Immunology Immunotherapy

Tumor BiologyTumor Immune MicroenvironmentCancer ImmunosurveillanceMedicineImmunology +10

Kinetics, prognostic and predictive values of <i>ESR1</i> circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor

Florian Clatot, Anne Perdrix, Laetitia Augusto, +21

Oncotarget

Pregnancy After Breast Cancer in Patients With Germline <i>BRCA</i> Mutations

Matteo Lambertini, Lieveke Ameye, Anne‐Sophie Hamy, +34

Journal of Clinical Oncology